tiprankstipranks
Trending News
More News >
Gt Biopharma, Inc. (GTBP)
NASDAQ:GTBP
US Market

GT Biopharma (GTBP) Income Statement

Compare
288 Followers

GT Biopharma Income Statement

Last quarter (Q3 2025), GT Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, GT Biopharma's net income was $-3.11M. See GT Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 14.36M$ 13.58M$ 21.26M$ 57.52M$ 6.76M
Depreciation and Amortization
$ 0.00$ 13.58M$ 0.00$ 0.00$ 4.00K
EBITDA
$ -13.16M$ 5.98M$ -20.96M$ -57.48M$ -24.97M
Operating Income
$ -14.36M$ -13.58M$ -21.26M$ -57.52M$ -6.76M
Other Income/Expenses
$ 1.20M$ 5.98M$ 373.00K$ -498.00K$ -21.53M
Pretax Income
$ -13.16M$ -7.60M$ -20.88M$ -58.01M$ -28.30M
Net Income
$ -13.16M$ -7.60M$ -20.88M$ -58.01M$ -28.30M
Per Share Metrics
Basic EPS
$ -6.94$ -5.64$ -0.66$ -2.06$ -6.45
Diluted EPS
$ -6.94$ -5.64$ -0.66$ -2.06$ -6.45
Weighted Average Shares Outstanding
1.90M 1.35M 31.87M 28.16M 4.38M
Weighted Average Shares Outstanding (Diluted)
1.90M 1.35M 31.87M 28.16M 4.38M
Currency in USD

GT Biopharma Earnings and Revenue History